EC approves Inlyta (Pfizer) for Real Cell Carcinoma - 05-Sep-2012
The European Commission (EC) has granted marketing authorization for Inlyta (axitinib) from Pfizer for the treatment of adult patients with advanced Renal Cell Carcinoma a type of kidney cancer, after failure of prior treatment with sunitinib or a cytokine. The Inlyta data demonstrates a statistically significant improvement in progression free survival compared with sorafenib, and supports the continued role for VEGFR-targeted therapy, following the first-line standard of care,Sutent.
Related News
Further results from TIVO-1 study of tivozanib (Aveo Oncology/ Astellas) for Renal Cell Carcinoma treatment
IQWiG review of Inlyta(Pfizer),Nexavar (Bayer)and Afinitor (Novartis) as treatments for Renal Cell Carcinoma
NICE rejects Inlyta(Pfizer) for treatment of Renal Cell Carcinoma
Rencarex (WILEX) programme in Renal Cell Carcinoma is cancelled
Inlyta (Pfizer) not superior to Nexavar in Renal Cell Carcinoma trial
Votrient (GSK) is non inferior to Sutent ( Pfizer) in COMPRAZ study for Renal Cell Carcinoma
Aveo files tivozanib at FDA for treatment of Renal Cell Carcinoma
EC approves Inlyta (Pfizer) for Real Cell Carcinoma
Related Oncology Information
Oncology Clinical Guidelines
Familial breast cancer: The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care
NICEProstate cancer: diagnosis and treatment
NICEOncology Clinical Trials
Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer
Clinicaltrials.gov 08 April 2013Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy (CONKO-007)
Clinicaltrials.gov 04 April 2013Oncology Medical Journal Abstracts
Bone mass density, fracture history, self-reported osteoporosis as proxy variables for estrogen and the risk of non-small-cell lung cancer—A population based cohort study, the HUNT study: Are proxy variables friends or faults?
Lung Cancer 24 April 2013Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis
Lung Cancer 22 April 2013Oncology Medical Apps
CCO Oncology inPractice
Free
Cancer Signs and Symptoms
Free
Related Oncology Drugs
- JEVTANA
- VOTRIENT 200 MG FILM-COATED TABLETS
- ROFERON-A PRE-FILLED SYRINGE
- FARESTON
- PERJETA 420 MG CONCENTRATE FOR SOLUTION FOR INFUSION
- VELCADE 3.5 MG POWDER FOR SOLUTION FOR INJECTION.
- VOTRIENT 200 MG AND 400 MG FILM COATED TABLETS
- CAELYX 2MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- REVLIMID
- PROLEUKIN
- MEGACE 160 MG TABLETS
- ONCOTICE
- HERCEPTIN 150MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- TEMODAL CAPSULES
- MITOMYCIN C
- GLIVEC
- PROCARBAZINE CAPSULES 50MG
- NASTROSA 1MG FILM-COATED TABLETS
- CYCLOPHOSPHAMIDE 50 TABLETS
- PHOTOFRIN
- IRESSA 250MG FILM-COATED TABLETS
- BICALUTAMIDE 150MG FILM-COATED TABLETS
- VESANOID 10MG SOFT CAPSULES
- LEVOFOLINIC ACID 50 MG/ML SOLUTION FOR INJECTION OR INFUSION
- CASODEX 150 MG FILM-COATED TABLETS.
- ONKOTRONE INJECTION
- EVOLTRA 1MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- FIRMAGON 80MG INJECTION
- ETOPOPHOS 100MG POWDER FOR SOLUTION FOR INJECTION
- DAUNOXOME INJECTION (LIPOSOMAL DAUNORUBICIN)
- VINCRISTINE SULPHATE 1 MG/ML INJECTION
- FEMARA
- FLUDARA ORAL 10 MG FILM-COATED TABLET
- XELODA 150MG AND 500MG FILM-COATED TABLETS
- TEPADINA 100 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- BICALUTAMIDE 50MG FILM-COATED TABLETS
- HYDREA 500 MG HARD CAPSULES
- FLUOROURACIL 25 MG/ML INJECTION
- SUTENT 12.5MG, 25MG, 37.5MG AND 50MG HARD CAPSULES
- CYPROSTAT 50MG
- YONDELIS SOLUTION FOR INFUSION.
- TAXOTERE 160MG/8ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ISOVORIN
- XALUPRINE
- NEXAVAR 200MG FILM-COATED TABLETS
- EFUDIX CREAM
- MITOXANTRONE (MITOZANTRONE) 2 MG/ML STERILE CONCENTRATE
- VOTRIENT 200 MG FILM-COATED TABLETS
- AVASTIN 25MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- TYVERB
- TAXOL
- NIPENT 10 MG POWDER FOR SOLUTION FOR INJECTION, POWDER FOR SOLUTION FOR INFUSION
- NOVGOS
- SPRYCEL 20MG, 50MG, 80MG, 100MG AND 140MG FILM COATED TABLETS
- HALAVEN 0.44 MG/ML SOLUTION FOR INJECTION
- KYTRIL TABLETS 1MG AND 2MG
- ZAVEDOS
- XAGRID 0.5MG HARD CAPSULE
- PARAPLATIN
- ERWINASE
- CYTARABINE INJECTION SOLUTION 20MG/ML AND 100MG/ML
- TAXOTERE 80MG/4ML CONCENTRATE FOR SOLUTION FOR INFUSION
- FIRMAGON 120MG INJECTION
- ZOLADEX
- HYCAMTIN 1MG AND 4MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- TAMOFEN (CARCINOMA)
- UTOVLAN
- PROSTAP 3 DCS
- PROSTAP SR
- ATRIANCE 5 MG/ML SOLUTION FOR INFUSION
- LEUKERAN TABLETS 2 MG
- TESTOSTERONE ENANTATE AMPOULES
- VEPESID SOFT CAPSULES 50 MG AND 100 MG
- NAVELBINE 10 MG / ML CONCENTRATE FOR SOLUTION FOR INFUSION
- MYOCET
- CARBOPLATIN 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- GEMCITABINE 200 MG POWDER FOR SOLUTION FOR INFUSION / GEMCITABINE 1 G POWDER FOR SOLUTION FOR INFUSION / GEMCITABINE 2 G POWDER FOR SOLUTION FOR INFUSION
- TAXOTERE 20MG/1ML CONCENTRATE FOR SOLUTION FOR INFUSION
- TARCEVA 25MG, 100MG AND 150MG FILM-COATED TABLETS
- CARDIOXANE 500MG POWDER FOR SOLUTION FOR INFUSION
- MAXTREX TABLETS 10 MG
- VINBLASTINE SULPHATE 1 MG/ML INJECTION
- ZALTRAP 25MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- PROSTAP SR DCS
- TOMUDEX
- LEUSTAT INJECTION
- MAXTREX TABLETS 2.5 MG
- GEMZAR 200MG POWDER FOR SOLUTION FOR INFUSION, GEMZAR 1000MG POWDER FOR SOLUTION FOR INFUSION
- SOLTAMOX
- MABTHERA 100MG AND 500MG CONCENTRATE FOR SOLUTION FOR INFUSION
- GLIADEL 7.7MG IMPLANT
- CYPROSTAT 100MG
- ROFERON-A 18MIU/0.6ML CARTRIDGE
- DOXORUBICIN 2MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- CAMPTO 20MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- TASIGNA 200 MG HARD CAPSULES
- CASODEX 50 MG FILM-COATED TABLETS
- ARIMIDEX 1MG FILM-COATED TABLET
- AROMASIN
- DACARBAZINE 100MG, 200MG, 500MG, 1000MG
- TOPOTECAN 4 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- GRANISETRON
- UFTORAL HARD CAPSULES
- PROVERA TABLETS 100 MG
- PHARMORUBICIN
- ELOXATIN 5 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- TAXCEUS 20MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- ESTRACYT CAPSULES
- FASLODEX 250 MG SOLUTION FOR INJECTION
- ERBITUX 5MG/ML SOLUTION FOR INFUSION
- PROSTAP 3 LEUPRORELIN ACETATE DEPOT INJECTION 11.25MG
- HYCAMTIN 0.25MG AND 1 MG HARD CAPSULE
Advert for Healthcare Professionals only